Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for ROSUVASTATIN

Ingredient

ROSUVASTATIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-ROSUVASTATIN	40MG	TABLET	Resolved	2021-05-06	2021-06-03	138907
TEVA-ROSUVASTATIN	40MG	TABLET	Resolved	2020-07-14	2021-05-06	120309
TEVA-ROSUVASTATIN	5MG	TABLET	Resolved	2020-07-14	2021-03-04	120312
TEVA-ROSUVASTATIN	5MG	TABLET	Resolved	2020-07-14	2021-03-04	120315
TEVA-ROSUVASTATIN	5MG	TABLET	Resolved	2020-07-14	2021-07-09	120318
TEVA-ROSUVASTATIN	10MG	TABLET	Resolved	2019-10-17	2019-12-19	96717
TEVA-ROSUVASTATIN	10MG	TABLET	Resolved	2020-07-14	2021-04-15	120238
TEVA-ROSUVASTATIN	10MG	TABLET	Resolved	2020-07-14	2021-04-15	120241
TEVA-ROSUVASTATIN	40MG	TABLET	Resolved	2020-07-14	2021-05-06	120306
TEVA-ROSUVASTATIN	10MG	TABLET	Resolved	2021-09-09	2022-03-26	145449

Previous
1
…
25
26
27
28
Next

Showing 261 to 270 of 277

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-ROSUVASTATIN	20MG	TABLET	Discontinued	2022-03-25	2022-03-26	157434
TEVA-ROSUVASTATIN	20MG	TABLET	Reversed	2025-05-28	2025-06-04	258765
TEVA-ROSUVASTATIN	40MG	TABLET	Discontinued	2022-03-25	2022-03-26	157437

Previous
1
…
3
4
5

Showing 41 to 43 of 43